NOVEL USE OF BCG IMMUNOGENIC FORMULATION EXPRESSING A HUMAN RESPIRATORY SYNCYTIAL VIRUS… Application WO-2021195797-A1 World Intellectual Property Organisation (WIPO) 07 Oct 2021